Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
179 Cards in this Set
- Front
- Back
Gram positive, catalase positive, coagulase positive cocci
|
Staphylococcus aureus
|
|
Causes toxic shock syndrome, scalded skin syndrome, and food poisoning
|
Staphylococcus aureus
|
|
Infects catheters using adherent biofilms
|
Staphylococcus epidermidis
|
|
Normal skin flora that often contaminates cultures; Novobiocin sensitive
|
Staphylococcus epidermidis
|
|
Causes UTIs in young, sexually active adults
|
Staphylococcus saprophyticus
|
|
Number one cause of meningitis, otitis media, pneumonia, sinusitis.
|
Streptococcus pneumoniae
|
|
Optochin resistant alpha hemolytic gram positive
|
Viridans strep
|
|
Causes pharyngitis, impetigo, scarlet fever
|
Streptococcus pyogenes
|
|
Antibodies to M protein of Strep pyogenes can give rise to
|
Rheumatic fever
|
|
Associated with colon cancer
|
Streptococcus bovis
|
|
Causes pneumonia, meningitis, and sepsis, mainly in babies.
|
Strep agalacticae
|
|
Gamma hemolytic gram positive that causes UTI, subacute endocarditis, biliary tract infx
|
Enterococcus
|
|
Pseudomembranous colitis, diarrhea (bug and toxin)
|
Clostridum difficile (Toxin A and Toxin B)
|
|
Gas gangrene (bug and toxin)
|
Clostridium perfringins
alpha toxin (lecithinase) |
|
Psuedomembranous colitis often follows what?
|
Broad spectrum antibiotic use (ie clindamycin and ampicillin)
|
|
Causes black eschar that can progress to bacteremia and death.
|
Cutaneous anthrax from Bacillus anthracis
|
|
Causes flulike symptoms that rapidly progress to fever, hemorrhage, mediastinitis, and shock
|
Pulmonary anthrax from Bacillus anthracis
|
|
Causes pseudomembranous pharyngitis (bug and toxin)
|
Corynebacterium diphtheriae
Diphtheria toxin |
|
What does DTaP vaccine protect against?
|
Diphtheria, Tetanus, and Pertussis
|
|
Major bacterial virulence factor for S. aureus and mechanism
|
Protein A binds Fc region of Ig to prevent opsonization and phagocytosis.
|
|
Bacterial virulence factor for S. pneumoniae, H. influenzae type B, and Neisseria; plus mechanism
|
IgA protease cleaves IgA in order to colonize respiratory mucosa.
|
|
Bacterial virulence factor for Group A Streptococcus
|
M protein to help prevent phagocytosis
|
|
Diphtheria toxin mechanism
|
Inactivates elongation factor 2 (EF2) via ADP ribosylation. This inhibits protein synthesis.
|
|
Lab diagnosis of Corynebacterium diphtheriae
|
Metachromatic (blue and red) granules; Elek test for toxin.
|
|
Corynebacterium diphtheriae treatment
|
Antitoxin + Pen G/erythromycin
|
|
Toxin produced by Clostridium tetani and mechanism
|
Tetanospasmin is an exotoxin that blocks glycine and GABA release from Renshaw cells in the spinal cord. This stops inhibition which results in spastic paralysis, trismus, and risus sardonicus.
|
|
Bolutinum toxin mechanism
|
Provents release of stimulatory signals at MSK junction. Causes floppy baby, flaccid paralysis.
|
|
Alphatoxin
|
Produced by Clostridium perfringens- degrades phospholipids (myonecrosis and hemolysis)
|
|
Streptolysin O
|
Streptococcus pyogenes. Lyses RBCs.
|
|
Superantigens that can cause shock
|
Exotoxin A and TSST-1: bring MHC II and TCR in proximity to cause lots of IFN-g and IL-2 release.
|
|
Treatment against obligate anaerobes
|
Obligate anaerobes include Clostridium, Bacteroides, Actinomyces. Treat with Metronidazole, Clindamycin.
|
|
Aminoglycosides are ineffective against anerobes
|
AGs require oxygen to enter the bacterial cell.
|
|
Bacillus anthracis toxin
|
Edema factor mimics adenylate cyclase enzyme to increase cAMP levels.
|
|
Listeria monocytogenes infection acquisition
|
UnpasteurizeMilk/cheese. Deli meats
Vaginal transmission during birth |
|
How listeria moves from cell to cell
|
"actin rockets"
|
|
Listeria monocytogenes infections
|
Pregnant women: amnionitis, septicemia, spontaneous abortion
Immunocompromised patients: meningitis Healthy individuals: Mild gastroenteritis |
|
Yellow sulfur granules
|
Actinomyces israelii
|
|
Actinomyces treatment
|
Penicillin
|
|
Nocardia Treatment
|
Sulfa drugs
|
|
Clinical use of penicillin
|
Gram positives (S. pneumo, S.pyo, actino)
Treponema pallidum (syphilis) Gram negative cocci (Neisseria) |
|
Clinical use of methicillin, nafcillin, dicloxacillin
|
Staph aureus
|
|
Clinical use of ampicillin, amoxicillin
|
HELPSS: Haemophilus influenzae, E. coli, Listeria monocytogenes, Proteus mirabilis, Salmonella, Shigella
|
|
Clinical use of ticarcillin, carbenicillin, piperacillin
|
Antipseudomonals-
Pseudomonas and gram negative rods. Use with clavulinic acid |
|
Name 3 beta lactamase inhibitors that enhance the spectrum of penicillin drugs
|
Clavulinic Acid
Sulbactam Tazobactam |
|
Augmentin
|
Amoxicilin +Clavulinic Acid
|
|
Unasyn
|
Ampicillin + Tazobactam
|
|
Timentin
|
Ticarcillin + Clavulinic Acid
|
|
Zosyn
|
Piparacillin + Tazobactam
|
|
Cefazolin
|
1st Gen Ceph
|
|
Cephalexin
|
1st gen ceph
|
|
Cefprozil
|
2nd gen ceph
|
|
Cefdinir
|
3rd gen ceph
|
|
Ceftriaxone
|
3rd gen ceph
|
|
Cefepime
|
4th gen ceph
|
|
Clinical uses for 1st generation cephalosporins
|
Gram positive cocci
Gram negative: Proteus, E. Coli, Klebsiella (PEcK) |
|
Clinical uses for 2nd generation cephalosporins
|
Gram positive cocci
Gram negatives: HEN PEcKS H. influenzae, Enterobacter aerogenes, Neisseria, Proteus, E. coli, Klebsiella, Serratia |
|
Clinical uses for 3rd generation cephs
|
Serious gram negative infections
Resistant Strep pneumo Ceftriaxone is 1st line for Neisseria gonorrhoeae |
|
Clinical uses for 4th generation cephs
|
"Big Gun"
Gram positive, negative, Pseudomonas |
|
Toxicity of Cephalosporins
|
Nephrotox with Aminoglycosides
Disulfiram like reacction with EtOH. |
|
Mechanism of action and clinical use of aztreonam
|
Inhibits cell wall synthesis (binds PBP3); only effective against Gram-negative rods. Use for penicillin-allergic patients and those with renal insufficiency who cannot tolerate aminoglycosides.
|
|
Drug that is always administered with imipenem.
|
Cilastatin- inhibits renal dehydropeptidase I to decrease inactivation of drug in renal tubules.
|
|
Clinical use of Imipenem and meropenem
|
Gram positive cocci, gram negative rods, and anaerobes
|
|
Clinical use of vancomycin
|
Serious gram positives- S. aureus, enterococci, Clostridium difficile.
|
|
Vancomycin toxic side effects
|
Nephrotoxicity, Ototoxicity, Thrombophlebitis, Red man syndrome
|
|
Mechanism of resistance to vancomycin
|
Change from D-ala D-ala to D-ala D-lac
|
|
How to prevent vancomycin flushing
|
Pretreat with antihistamines
|
|
Next step in treatment of otitis media if resistant to amoxicillin
|
Augmentin
|
|
Prophylaxis against bacterial endocarditis
|
Cephalexin
|
|
Increases nephrotoxicity of aminoglycosides
|
Cephalosporins
|
|
Single dose treatment for gonorrhea
|
Ceftriaxone
|
|
Treatment for C. diff colitis
|
Oral vancomycin
|
|
Potential consequence of silicosis of the lungs
|
Increase TB susceptibility
|
|
Components of Gohn complex
|
Fibrosis+ Scar + Lymphadenopathy (Hilar lmph nodes)
|
|
What does the Ghon complex indicate?
|
Primary tuberculosis infection
|
|
Where does secondary TB typically occur?
|
Apex of the lung
|
|
Extrapulmonary tuberculosis in the vertebrae
|
Pott's disease
|
|
Most common extrapulmonary tuberculosis
|
Kidneys (sterile pyuria)
|
|
Mycobacteria staining
|
All mycobacteria are acid fast organisms
|
|
Bug that causes Leprosy
|
Mycobacterium leprae
|
|
Reservoir for Mycobacterium leprae in the USA
|
Armadillos
|
|
Mycobacterium leprae treatment
|
Dapsone
|
|
Two types of Hansen's disease
|
(Leprosy has two forms):
Lepromatous: diffusely over skin, communicable; low cell mediated immunity Tuberculoid: A few skin plaques |
|
Obligate aerobes
|
Use an O2 dependent system to generate ATP.
Nocardia, Pseudomonas aeruginosa, Mycobacterium tuberculosis, Bacillus |
|
Causes pulmonary TB like symptoms in COPD patients
|
Mycobacterium kasasii
|
|
Positive PPD indicates
|
Current infection
Vaccination Previous infection/exposure |
|
Treatment for M. tuberculosis
|
Rifampin
Isonizid Pyrazinamide Ethambutol |
|
Prophylaxis for M. tuberculosis
|
Isoniazid
|
|
Prophylaxis for M. avium intracellulare
|
Azithromycin
|
|
Treatment for M. avium intracellulare
|
Azithromycin, rifampin, ethambutol, streptomycin
|
|
Mechanism of action of isonizid
|
Decreases synthesis of mycolic acids (components of the cell wall)
|
|
Side effects of isoniazid
|
Neurotoxicity, hepatotoxicity, lupus.
|
|
Administered to prevent neurotoxicity and lupus due to isonizid
|
Vitamin B6
|
|
Drugs known to cause drug induced lupus
|
Isoniazid
Hydralazine Procainamide |
|
4 Rs of Rifampin
|
RNA Polymerase inhibitor
Revs up microsomal P450 Red/Orange body fluids Rapid resistance if used alone |
|
Clinical use of Rifampin
|
-Mycobacterium tuberculosis
-Delays resistance to dapsone when used for leprosy -Meningococcal prophylaxis and chemoprophylaxis in contacts of children with HIB |
|
Important side effect of ethambutol
|
Reversible red green color blindness (optic neuropathy)
|
|
Mechanism of action of Rifampin
|
Inhibits DNA dependent RNA Polymerase
|
|
Three spirochetes
|
Borrelia
Leptospira Treponema (BLT) |
|
Question mark shaped bacteria found in water contaminated with animal urine
|
Leptospira interrogans
|
|
Mechanism of action of isonizid
|
Decreases synthesis of mycolic acids (components of the cell wall)
|
|
Side effects of isoniazid
|
Neurotoxicity, hepatotoxicity, lupus.
|
|
Administered to prevent neurotoxicity and lupus due to isonizid
|
Vitamin B6
|
|
Drugs known to cause drug induced lupus
|
Isoniazid
Hydralazine Procainamide |
|
4 Rs of Rifampin
|
RNA Polymerase inhibitor
Revs up microsomal P450 Red/Orange body fluids Rapid resistance if used alone |
|
Clinical use of Rifampin
|
-Mycobacterium tuberculosis
-Delays resistance to dapsone when used for leprosy -Meningococcal prophylaxis and chemoprophylaxis in contacts of children with HIB |
|
Important side effect of ethambutol
|
Reversible red green color blindness (optic neuropathy)
|
|
Mechanism of action of Rifampin
|
Inhibits DNA dependent RNA Polymerase
|
|
Three spirochetes
|
Borrelia
Leptospira Treponema (BLT) |
|
Question mark shaped bacteria found in water contaminated with animal urine
|
Leptospira interrogans
|
|
Flulike symptoms, photophobia, Jaundice, Conjunctivities
|
Leptospirosis caused by Leptospira interrogans
|
|
Weil's disease
|
Severe Leptospira interrogans infection.
|
|
Lyme disease cause and vector
|
Borrelia burgdorferi; Ixodes tick
|
|
Lyme disease Stage 1
|
Erythema chronicum migrans, flulike symptoms
|
|
Lyme disease Stage 2
|
Neurologic and cardiac manifestations (Bell's palsy, myopericarditis)
|
|
Lyme disease Stage 3
|
Chronic monoarthritis and migratory polyarthritis
|
|
Lyme disease treatment
|
Doxycycline early
Ceftriaxone late |
|
Cat Scratch
|
Bartonella spp.
|
|
Ixodes ticks
|
Borrelia burgdorferi and Babesia
|
|
Recurrent fever from louse
|
Borrelia recurrentis
|
|
Puppy poop
|
Campylobacter
|
|
Parrots
|
Chlamydophila psittaci
|
|
Spores from tick feces and cattle placenta cause Q fever
|
Coxiella burnetti
|
|
Lone Star Tick
|
Ehrlichoiosis chaffeensis
|
|
Ticks, rabbits, deer fly
|
Francisella tularensis
|
|
Animal urine, especially in surfers and in tropical areas
|
Leptospira spp.
|
|
Animal bite, cats, dogs; causing cellulitis, osteomyelitis
|
Pateurella multocida
|
|
Louse causing epidemic typus
|
Rickettsia powazekii
|
|
Dermacentor tick bite
|
Rickettsia rickettsii
|
|
Fleas leading to endemic typhus
|
Ricketssia typhus
|
|
Bubonic plague
|
Yersinia pestis
|
|
Yersinia pestis
|
Flea bite, rodents, prarie dogs
|
|
Puppy feces, children, diarrhea in daycare centers
|
Yersinia enterocolitica
|
|
Vaginal epithelial cells covered with bacteria visible under microscope
|
Clue cells of Garnerella Vaginalis
|
|
Gray vaginal dischare with a fishy smell; non painful
|
Gardnerella vaginalis
|
|
Headache, fever, rash that starts on hands and feet (vasculitis)
|
Rocky Mountain spotted fever from Rickettsia rickettsii
|
|
Rash starts centrally and spreads out, sparing palms and soles
|
Ricketssia prowazekii
|
|
List of rickettsial organisms and treatment
|
Rickettsia ricketsii; R. typhi; R. prowzekii; Ehrlichia; Coxiella burnetti
|
|
Bacteria that can't make own ATP
|
Chlamydia and Rickettsia
|
|
Patient serum is mixed with Proteus antigens; antibodies cross react to Proteus O antigens and agglutinate
|
Weil Felix Reaction
|
|
Elementary body enters cell via endocytosis; Reticulate body replicates in the ell by fission
|
Chlamydiae
|
|
Chlamydia treatment
|
Azithromycin or Doxycycline
|
|
Mycoplasma pneumoniae
|
Azithromycin
Tetracycline Erythromycin |
|
Chocolate agar
|
Haemophilus influenzae
|
|
Thayer Martin or VPN media
|
Neisseria gonorrhoeae
|
|
Bordet-Gengou (potato) agar
|
Bordatella pertussis
|
|
Tellurite Plate, Loffler's media
|
Corynebacterium diphtheriae
|
|
Lowenstein Jensen agar
|
M. tuberculosis
|
|
Pink colonies on MacConkey's agar
|
Klebsiella, E. coli, Enterobacter
|
|
Charcoal yeast extract
|
Legionella
|
|
Fitz-Hugh-Curtis syndrome
|
Gonorrhoeae + extensive disease (gets to liver)
seen with Neisseria gonorrhoea infection |
|
Waterhouse-Friederichsen syndrome
|
Adrenal gland failure due to bleeding into the gland caused by Neisseria meningitidis infection.
|
|
Rx: erythromycin eyedrops
|
To prevent ophthalmia neonatorum (vertical transmission of neisseria gonorrheae during delivery)
|
|
Epiglottitis Meningitis Otitis media Pneumonia
|
HaEMOPhilus influenzae
|
|
X ray finding of epiglottitis
|
Thumb sign
|
|
Legonnaires diseaes
|
Severe pneumonia and fever
|
|
Pontiac fever
|
Mild flulike syndrome
|
|
Silver stain
|
Legionella pneumophila
|
|
Treatment for Legionella pneumophila
|
Erythromycin
|
|
Pneumonia in cystic fibrosis
|
Pseudomonas
|
|
Pseudomonas aeruginosa tx
|
Aminoglycoside plus extended spectrum penicillin (piperacillin, ticarcillin)
|
|
H. pylori triple therapy
|
PPI, clarithromycin, amoxicillin or metronidazole
|
|
Drug classes that inhibit protein synthesis
|
Aminoglycosides
Tetracyclines Chloramphenicol Clindamycin Erythromycin Linezolid buy AT 30, CCEL at 50 |
|
Aminoglycosides MOA
|
Prevent formation of initiation complex
|
|
Tetracyclines MOA
|
Inhibit tRNA binding
|
|
Macrolides MOA
|
Inhibit protein synthesis by blocking translocation
|
|
Chloramphenicol MOA
|
Blocks peptide bond formation at 50S ribosomal subunit.
|
|
Clindamycin MOA
|
Blocks peptide bond formation at 50S subunit
|
|
Clinical use against severe gram negative rod infections
|
Aminoglycosides
|
|
Clinical use against Borrelia burgdorferi, M. pneumoniae, Rickettsia, Chlamydia
|
Tetracyclines
|
|
Clinical use agains Atypical pneumonias
|
Macrolides
|
|
Clinical use against meningitis
|
Chloramphenicol
|
|
Clinical use against anaerobic infections in aspiration pneumonia or lung abscesses
|
Clindamycin
|
|
Treats anerobes above the diaphragm
|
Clindamycin
|
|
Treats anerobes below the diaphragm
|
Metronidazole
|
|
Nephrotoxic, Ototoxic, Teratogenicity are toxicities
|
Aminoglycosides
|
|
GI distress, Discoloration of teeth, photosensitivity are toxicities
|
Tetracyclines
|
|
Prolonged QT interval, GI discomfort
|
Macrolides
|
|
Gray baby syndrome is toxicity
|
Chloramphenicol
|
|
Pseudomembranous colitis, fever, diarrhea toxicity
|
Clindamycin
|